Digestive System
Focusing on gastric ulcers, functional dyspepsia, and non-alcoholic fatty liver disease, we specialize in quality control for gastric pH monitoring of proton pump inhibitor (PPI) drugs, building an efficient and precise clinical R&D service platform for innovative gastrointestinal therapeutics.
INTRODUCTION
Digestive system diseases encompass a wide range of conditions affecting the entire digestive tract from the mouth to the anus, along with its associated organs. These disorders not only impact patients' daily quality of life but can also lead to serious complications. With changing lifestyles and an aging population, the incidence of digestive system diseases is on the rise, particularly conditions such as gastrointestinal ulcers, functional dyspepsia, and non-alcoholic fatty liver disease.
Boji Pharmaceutical possesses extensive expertise and resources in gastroenterology project operations, collaborating with over a hundred research centers. Multiple products have successfully passed on-site inspections. The company excels in quality control for gastric pH monitoring during PK/PD trials involving PPI drugs, ensuring the accuracy of research outcomes.
Clinical Research Project Experience
- Gastric and duodenal ulcers and ulcer bleeding
- Functional dyspepsia
- Non-alcoholic fatty liver disease, etc.
PROJECT EXPERIENCE
Facilitating the Successful Approval and Market Launch of Ranitidine Hydrochloride for Injection
Leveraging its extensive experience and efficient execution in chemical drug R&D, the company assisted clients in successfully completing clinical studies and documentation organization that met technical requirements, thereby effectively ensuring the smooth review and approval of the product.